Macuga A. Daniel's most recent trade in Usana Health Sciences Inc was a trade of 3,791 Common Stock done at an average price of $47.1 . Disclosure was reported to the exchange on May 2, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Sale of securities on an exchange or to another person at price $ 47.14 per share. | 02 May 2024 | 3,791 | 0 (0%) | 0% | 47.1 | 178,717 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Sale of securities on an exchange or to another person at price $ 47.14 per share. | 02 May 2024 | 3,791 | 0 (0%) | 0% | 47.1 | 178,717 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Sale of securities on an exchange or to another person at price $ 48.08 per share. | 01 Mar 2024 | 1,500 | 3,791 (0%) | 0% | 48.1 | 72,120 | Common Stock |
| Usana Health Sciences Inc | A. Macuga Daniel | CHIEF COMMUNICATIONS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 11,574 | 23,920 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel Macuga A. | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,676 | 6,001 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Macuga Daniel A. | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,676 | 12,346 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Macuga A. Daniel | CHIEF COMMUNICATIONS OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.85 per share. | 08 Feb 2024 | 710 | 5,291 (0%) | 0% | 50.9 | 36,104 | Common Stock |
| Usana Health Sciences Inc | Daniel Macuga A. | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 2,503 | 15,602 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 2,503 | 4,476 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 1,580 | 4,995 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 1,580 | 14,022 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | A. Macuga Daniel | CHIEF COMMUNICATIONS OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.80 per share. | 06 Feb 2024 | 1,061 | 3,415 (0%) | 0% | 47.8 | 50,716 | Common Stock |
| Usana Health Sciences Inc | Macuga A. Daniel | CHIEF COMMUNICATIONS OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.71 per share. | 06 Feb 2024 | 670 | 4,325 (0%) | 0% | 49.7 | 33,306 | Common Stock |
| Usana Health Sciences Inc | A. Daniel Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 2,201 | 2,979 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | A. Macuga Daniel | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 2,201 | 18,105 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Macuga Daniel A. | CHIEF COMMUNICATIONS OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.23 per share. | 03 Feb 2024 | 1,006 | 1,973 (0%) | 0% | 47.2 | 47,513 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Sale of securities on an exchange or to another person at price $ 62.88 per share. | 14 Jun 2023 | 2,234 | 778 (0%) | 0% | 62.9 | 140,474 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Sale of securities on an exchange or to another person at price $ 62.22 per share. | 17 Feb 2023 | 3,012 | 3,012 (0%) | 0% | 62.2 | 187,407 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 10,011 | 23,564 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,677 | 6,735 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,677 | 20,306 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,581 | 21,983 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,581 | 5,728 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.53 per share. | 06 Feb 2023 | 711 | 6,024 (0%) | 0% | 61.5 | 43,748 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.76 per share. | 06 Feb 2023 | 670 | 5,058 (0%) | 0% | 59.8 | 40,039 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 2,200 | 14,713 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 2,200 | 4,434 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,160 | 4,639 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,160 | 13,553 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.04 per share. | 03 Feb 2023 | 955 | 3,479 (0%) | 0% | 60.0 | 57,338 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.04 per share. | 03 Feb 2023 | 492 | 4,147 (0%) | 0% | 60.0 | 29,540 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | Sale of securities on an exchange or to another person at price $ 53.92 per share. | 05 Dec 2022 | 1,474 | 2,234 (0%) | 0% | 53.9 | 79,475 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 6,322 | 18,590 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 1,677 | 4,419 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 1,677 | 16,913 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.30 per share. | 07 Feb 2022 | 711 | 3,708 (0%) | 0% | 94.3 | 67,047 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 2,201 | 2,201 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 2,201 | 14,827 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,399 | 3,335 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,399 | 12,268 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,160 | 2,428 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,160 | 13,667 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.82 per share. | 03 Feb 2022 | 933 | 1,268 (0%) | 0% | 93.8 | 87,534 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 03 Feb 2022 | 593 | 2,742 (0%) | 0% | 92.3 | 54,746 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 03 Feb 2022 | 492 | 1,936 (0%) | 0% | 92.3 | 45,421 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Sale of securities on an exchange or to another person at price $ 100.86 per share. | 08 Dec 2021 | 368 | 0 (0%) | 0% | 100.9 | 37,116 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2021 | 639 | 17,028 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2021 | 639 | 639 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.84 per share. | 23 Oct 2021 | 271 | 368 (0%) | 0% | 99.8 | 27,057 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Sale of securities on an exchange or to another person at price $ 92.00 per share. | 22 Feb 2021 | 3,930 | 0 (0%) | 0% | 92 | 361,560 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2021 | 6,707 | 17,667 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 873 | 4,300 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 873 | 10,960 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.20 per share. | 06 Feb 2021 | 370 | 3,930 (0%) | 0% | 84.2 | 31,154 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 2,201 | 2,568 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 2,201 | 14,945 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,398 | 11,833 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,398 | 4,020 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,161 | 2,796 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,161 | 13,784 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.76 per share. | 03 Feb 2021 | 933 | 1,635 (0%) | 0% | 82.8 | 77,215 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.20 per share. | 03 Feb 2021 | 593 | 3,427 (0%) | 0% | 84.2 | 49,931 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 553 | 2,857 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 553 | 13,231 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.18 per share. | 03 Feb 2021 | 492 | 2,304 (0%) | 0% | 85.2 | 41,909 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.18 per share. | 03 Feb 2021 | 235 | 2,622 (0%) | 0% | 85.2 | 20,017 | Common Stock |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 638 | 2,190 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 638 | 17,146 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Daniel A. Macuga | Chief Communications Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.86 per share. | 23 Oct 2020 | 271 | 1,919 (0%) | 0% | 85.9 | 23,268 | Common Stock |